Xofigo RA 223 injections
Ended Awarded Last action
- Contract number
- 36C26019F0033
- Awardee
-
Bayer Healthcare Pharmaceuticals Inc. UEI V1EVGCK7XES8
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $180,662
Award facts
- Opportunity
-
- XOFIGO Ra-223 Injections 663-C95092 POP: 11/1/2018 - 10/31/2019 Award Notice · Posted Oct 29, 2018
- Contract value 100% obligated
- $180,662.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Whippany, Hanover, NJ 07981, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$175,423 | |
| Original award | $356,085 |
About this award
This federal contract award is for the delivery of XOFIGO RA 223 injections to the Department of Veterans Affairs (VA) Veterans Health Administration. The prime contractor is Bayer Healthcare Pharmaceuticals Inc., a foreign-owned for-profit organization that specializes in the research, development, and marketing of pharmaceutical products.
The contract was awarded on a firm fixed price basis under Bayer's General Services Administration (GSA) Federal Supply Schedule (FSS) 61-IB contract for Pharmaceuticals and Drugs, with a potential value of $180,662.36. This appears to be a delivery order awarded without any set-aside designation. Bayer has previously supplied specialty pharmaceuticals like Xarelto, Adempas, and Xofigo to the VA and the Defense Logistics Agency (DLA) under various indefinite delivery contracts and blanket purchase agreements, leveraging its FSS pricing to support the procurement of essential medical products for veterans, active duty military, and their dependents.
Quick answers
Who was awarded contract 36C26019F0033?
36C26019F0033 was awarded to Bayer Healthcare Pharmaceuticals Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on November 1, 2018.
How much is contract 36C26019F0033 worth?
The government has obligated $180,662 on 36C26019F0033.
Is contract 36C26019F0033 an order under another contract?
Yes. 36C26019F0033 is a delivery order under V797P2202D, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26019F0033 competed?
The extent of competition for 36C26019F0033 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award